Clinical Lymphoma Myeloma and Leukemia (CLML)

Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Clinical Lymphoma Myeloma and Leukemia (CLML) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cancer Research, Oncology, Hematology, macroglobulinemia, amyloidosis, plasma-cell dyscrasias, lymphoma, myeloma and leukemia, clinical research and mechanistic approaches, drug sensitivity and resistance, gene and antisense therapy, pathology, markers, prognostic indicators , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2152-2650, E-ISSN: 2152-2669, Established: 2001, Impact Factor: 2.7
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE